Scroll Back to Top
Contact Us
Case Study

Maximizing data from a limited patient population through an adapted FIH SAD/MAD design

Download PDF

Fortrea was initially tasked with adding a single cohort of CAD patients to an already approved Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) study in healthy participants, based on promising PD data. The study was designed to assess safety, tolerability, PK and PD.

Book a Meeting

Choose how you like to connect.

We've been driving innovation with our tailored clinical solutions for 30+ years. Let's connect.

Write to us
Book a Meeting

Prefer to send an inquiry?

Tell us about your needs and our team will follow up shortly.

* denotes required fields

Service Interest(s)
(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif, jpg, jpeg, png, bmp, txt, rtf, html, pdf, doc, docx, ppt, pptx, xls, xlsx, xml.

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Explore Careers at Fortrea

Join our Site Network

Learn more about participating in a Fortrea Clinical Trial

Need to speak directly with our sales team?

Connect with our sales team to discuss your needs and explore the right solutions for your clinical development goals — quick, clear, and hassle‑free.

Book a Meeting